NousQ Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Series A
- (Upcoming)
- Investors
-
10
NousQ General Information
Description
Developer of tube insertion surgery technology intended to commercialise medical technology and devices for patients. The company's product offers a novel resolution for glue ears, uniquely programmed by a sensor and an automated algorithm adaptable for different eardrums, enabling clients to reduce cost, surgery risks, and glue ear-related complications.
Contact Information
Website
www.nousq.comCorporate Office
- 73 Ayer Rajah Crescent
- Number 02-25, Launchpad One-North
- Singapore, 139952
- Singapore
Corporate Office
- 73 Ayer Rajah Crescent
- Number 02-25, Launchpad One-North
- Singapore, 139952
- Singapore
NousQ Timeline
NousQ Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC (Series A) | Upcoming | Generating Revenue | ||||
| 10. Early Stage VC | 27-May-2025 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 11-Oct-2023 | Completed | Generating Revenue | |||
| 7. Seed Round | 12-Sep-2023 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Aug-2023 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jan-2023 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 12-Oct-2022 | Completed | Generating Revenue | |||
| 3. Grant | 01-Mar-2022 | $225K | $1.32M | Completed | Generating Revenue | |
| 2. Seed Round | 01-Oct-2021 | $1.32M | $1.32M | Completed | Generating Revenue |
NousQ Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Pre Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NousQ Patents
NousQ Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026235618-A1 | Method and apparatus for automated incision of the tympanic membrane | Pending | 06-May-2025 |
NousQ Signals
NousQ Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BE Health Ventures | Venture Capital | Minority | ||
| QUAY Acceleration | Accelerator/Incubator | |||
| Scaler8 | Accelerator/Incubator | |||
| DayDayUp | Accelerator/Incubator | |||
| MedTech Innovator | Accelerator/Incubator |
NousQ FAQs
-
When was NousQ founded?
NousQ was founded in 2021.
-
Where is NousQ headquartered?
NousQ is headquartered in Singapore, Singapore.
-
What is the size of NousQ?
NousQ has 11 total employees.
-
What industry is NousQ in?
NousQ’s primary industry is Surgical Devices.
-
Is NousQ a private or public company?
NousQ is a Private company.
-
What is NousQ’s current revenue?
The current revenue for NousQ is .
-
How much funding has NousQ raised over time?
NousQ has raised $9.6M.
-
Who are NousQ’s investors?
BE Health Ventures, QUAY Acceleration, Scaler8, DayDayUp, and MedTech Innovator are 5 of 10 investors who have invested in NousQ.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process